{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T19:33:33Z","timestamp":1773084813009,"version":"3.50.1"},"reference-count":64,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glucocorticoids are integral to successful treatment of childhood acute lymphoblastic leukemia (ALL) and other lymphoid malignancies. A large body of data indicates that in various model systems, elevation of cyclic adenosine monophosphate (cAMP) can potentiate glucocorticoid response, although this has not been well evaluated as a potential leukemia treatment. Although cAMP analogs have been studied, little data exist regarding the potential toxicity to leukemia cells of pharmacologic elevation of cAMP levels in leukemic blasts. Using MTT assays of cell proliferation on CEM ALL cells, we found that aminophylline and other nonspecific phosphodiesterase (PDE) inhibitors suppress cell growth. This effect is replicated by the PDE4-specific PDE inhibitor rolipram, but not by specific inhibitors of the PDE1 or PDE3 classes. We found that PDE inhibitors cause increased dexamethasone sensitivity and a synergistic effect with the adenylyl cyclase activator forskolin. We observed several important cellular characteristics associated with this treatment, including elevation of cAMP, induction of p53 and p21WAF1\/CIP1proteins, G1 and G2\/M cell cycle arrest, and increased apoptosis. Sensitivity to forskolin and rolipram is shared by at least 2 pediatric ALL cell lines, CEM and Reh cells. Some cell lines derived from adult-type lymphoid malignancies also show sensitivity to this treatment. These findings suggest that PDE inhibitors have therapeutic potential in human ALL and characterize the molecular mechanisms that may be involved in this response.<\/jats:p>","DOI":"10.1182\/blood.v99.9.3390","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:33:52Z","timestamp":1034361232000},"page":"3390-3397","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":73,"title":["Inhibition of PDE4 phosphodiesterase activity induces growth suppression, apoptosis, glucocorticoid sensitivity, p53, and p21WAF1\/CIP1 proteins in human acute lymphoblastic leukemia cells"],"prefix":"10.1182","volume":"99","author":[{"given":"Ryosuke","family":"Ogawa","sequence":"first","affiliation":[{"name":"From the Division of Hematology, Department of Pediatrics, Department of Medicine and the Johns Hopkins Oncology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Streiff","sequence":"additional","affiliation":[{"name":"From the Division of Hematology, Department of Pediatrics, Department of Medicine and the Johns Hopkins Oncology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artem","family":"Bugayenko","sequence":"additional","affiliation":[{"name":"From the Division of Hematology, Department of Pediatrics, Department of Medicine and the Johns Hopkins Oncology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory J.","family":"Kato","sequence":"additional","affiliation":[{"name":"From the Division of Hematology, Department of Pediatrics, Department of Medicine and the Johns Hopkins Oncology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021300143092500_B1","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1182\/blood.V94.4.1209","article-title":"Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia.","volume":"94","author":"Dordelmann","year":"1999","journal-title":"Blood."},{"key":"2020021300143092500_B2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/978-1-4615-4811-9_66","article-title":"Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia.","volume":"457","author":"Gaynon","year":"1999","journal-title":"Adv Exp Med Biol."},{"key":"2020021300143092500_B3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-2008-1026781","article-title":"Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83).","volume":"199","author":"Riehm","year":"1987","journal-title":"Klin Padiatr."},{"key":"2020021300143092500_B4","first-page":"431","article-title":"Glucocorticoid receptors and steroid sensitivity in normal and neoplastic human lymphoid tissues: a review.","volume":"44","author":"Homo-Delarche","year":"1984","journal-title":"Cancer Res."},{"key":"2020021300143092500_B5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000226435","article-title":"Glucocorticoid receptors predict response to combination chemotherapy in patients with acute lymphoblastic leukemia.","volume":"44","author":"Iacobelli","year":"1987","journal-title":"Oncology."},{"key":"2020021300143092500_B6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF01026388","article-title":"Glucocorticoid receptors and sensitivity in leukemias.","volume":"42","author":"Ho","year":"1981","journal-title":"Blut."},{"key":"2020021300143092500_B7","first-page":"4251","article-title":"Clinical implications of glucocorticoid receptors in human leukemia.","volume":"38","author":"Lippman","year":"1978","journal-title":"Cancer Res."},{"key":"2020021300143092500_B8","first-page":"4801","article-title":"Glucocorticoid receptors in childhood acute lymphocytic leukemia.","volume":"42","author":"Costlow","year":"1982","journal-title":"Cancer Res."},{"key":"2020021300143092500_B9","first-page":"6482","article-title":"Glucocorticoid receptors in immunological subtypes of childhood acute lymphocytic leukemia cells: a Pediatric Oncology Group Study.","volume":"45","author":"Quddus","year":"1985","journal-title":"Cancer Res."},{"key":"2020021300143092500_B10","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1182\/blood.V82.8.2304.2304","article-title":"High glucocorticoid receptor content of leukemic blasts is a favorable prognostic factor in childhood acute lymphoblastic leukemia.","volume":"82","author":"Kato","year":"1993","journal-title":"Blood."},{"key":"2020021300143092500_B11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0303-7207(84)90089-3","article-title":"Cellular receptor levels and glucocorticoid responsiveness of lymphoma cells.","volume":"36","author":"Gehring","year":"1984","journal-title":"Mol Cell Endocrinol."},{"key":"2020021300143092500_B12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0092-8674(77)90060-5","article-title":"Diploid and haploid states of the glucocorticoid receptor gene of mouse lymphoid cell lines.","volume":"11","author":"Bourgeois","year":"1977","journal-title":"Cell."},{"key":"2020021300143092500_B13","first-page":"967","article-title":"Transcriptional control of steroid-regulated apoptosis in murine thymoma cells.","volume":"10","author":"Chapman","year":"1996","journal-title":"Mol Endocrinol."},{"key":"2020021300143092500_B14","first-page":"1378","article-title":"Glucocorticoid-induced cell death requires autoinduction of glucocorticoid receptor expression in human leukemic T cells.","volume":"59","author":"Ramdas","year":"1999","journal-title":"Cancer Res."},{"key":"2020021300143092500_B15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1073\/pnas.70.1.76","article-title":"Induction of cytolysis of cultured lymphoma cells by adenosine 3\u2032:5\u2032-cyclic monophosphate and the isolation of resistant variants.","volume":"70","author":"Daniel","year":"1973","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021300143092500_B16","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.4049\/jimmunol.154.4.1634","article-title":"TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes.","volume":"154","author":"Lomo","year":"1995","journal-title":"J Immunol."},{"key":"2020021300143092500_B17","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/intimm\/5.9.1085","article-title":"Distribution of cAMP in secondary follicles and its expression in B cell apoptosis and CD40-mediated survival.","volume":"5","author":"Knox","year":"1993","journal-title":"Int Immunol."},{"key":"2020021300143092500_B18","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.4049\/jimmunol.145.4.1227","article-title":"Agents that elevate cAMP stimulate DNA fragmentation in thymocytes.","volume":"145","author":"McConkey","year":"1990","journal-title":"J Immunol."},{"key":"2020021300143092500_B19","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1016\/S0021-9258(19)34118-3","article-title":"Adenosine receptor-mediated accumulation of cyclic AMP-induced T-lymphocyte death through internucleosomal DNA cleavage.","volume":"265","author":"Kizaki","year":"1990","journal-title":"J Biol Chem."},{"key":"2020021300143092500_B20","first-page":"1781","article-title":"Cyclic adenosine-3\u2032,5\u2032-monophosphate-mediated cytotoxicity in steroid sensitive and resistant myeloma.","volume":"3","author":"Krett","year":"1997","journal-title":"Clin Cancer Res."},{"key":"2020021300143092500_B21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/sj.leu.2401237","article-title":"Theophylline-induced B-CLL apoptosis is partly dependent on cyclic AMP production but independent of CD38 expression and endogenous IL-10 production [in process citation].","volume":"13","author":"Mentz","year":"1999","journal-title":"Leukemia."},{"key":"2020021300143092500_B22","first-page":"199","article-title":"Mechanism of lymphoma cell death induced by cyclic AMP.","volume":"81","author":"Coffino","year":"1975","journal-title":"Am J Pathol."},{"key":"2020021300143092500_B23","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.4049\/jimmunol.155.10.4525","article-title":"Functional glucocorticoid receptor expression is required for cAMP-mediated apoptosis in a human leukemic T cell line.","volume":"155","author":"Kiefer","year":"1995","journal-title":"J Immunol."},{"key":"2020021300143092500_B24","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1126\/science.1749936","article-title":"Dopaminergic and ligand-independent activation of steroid hormone receptors.","volume":"254","author":"Power","year":"1991","journal-title":"Science."},{"key":"2020021300143092500_B25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0303-7207(96)04012-9","article-title":"Crosstalk during Ca2+\u2212, cAMP\u2212, and glucocorticoid-induced gene expression in lymphocytes.","volume":"128","author":"Dowd","year":"1997","journal-title":"Mol Cell Endocrinol."},{"key":"2020021300143092500_B26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0960-0760(99)00063-1","article-title":"Glucocorticoids, oxysterols, and cAMP with glucocorticoids each cause apoptosis of CEM cells and suppress c-myc.","volume":"69","author":"Thompson","year":"1999","journal-title":"J Steroid Biochem Mol Biol."},{"key":"2020021300143092500_B27","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1016\/S0021-9258(19)89191-3","article-title":"Cyclic AMP-dependent protein kinase promotes glucocorticoid receptor function.","volume":"261","author":"Gruol","year":"1986","journal-title":"J Biol Chem."},{"key":"2020021300143092500_B28","first-page":"3684","article-title":"Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.","volume":"58","author":"Medh","year":"1998","journal-title":"Cancer Res."},{"key":"2020021300143092500_B29","first-page":"1451","article-title":"Modulation of glucocorticoid receptor function by protein kinase A.","volume":"6","author":"Rangarajan","year":"1992","journal-title":"Mol Endocrinol."},{"key":"2020021300143092500_B30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0968-0004(97)01050-5","article-title":"Tailoring cAMP-signaling responses through isoform multiplicity.","volume":"22","author":"Houslay","year":"1997","journal-title":"Trends Biochem Sci."},{"key":"2020021300143092500_B31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0955-0674(99)00073-3","article-title":"Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions.","volume":"12","author":"Soderling","year":"2000","journal-title":"Curr Opin Cell Biol."},{"key":"2020021300143092500_B32","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1152\/physrev.1995.75.4.725","article-title":"Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms.","volume":"75","author":"Beavo","year":"1995","journal-title":"Physiol Rev."},{"key":"2020021300143092500_B33","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/sj.bjp.0701688","article-title":"Phosphodiesterase profile of human B lymphocytes from normal and atopic donors and the effects of PDE inhibition on B cell proliferation.","volume":"123","author":"Gantner","year":"1998","journal-title":"Br J Pharmacol."},{"key":"2020021300143092500_B34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02737809","article-title":"Expression and regulation of mRNA for distinct isoforms of cAMP-specific PDE-4 in mitogen-stimulated and leukemic human lymphocytes.","volume":"28","author":"Jiang","year":"1998","journal-title":"Cell Biochem Biophys."},{"key":"2020021300143092500_B35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1042\/bj3210165","article-title":"Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.","volume":"321","author":"Erdogan","year":"1997","journal-title":"Biochem J."},{"key":"2020021300143092500_B36","doi-asserted-by":"crossref","first-page":"20575","DOI":"10.1074\/jbc.273.32.20575","article-title":"Induction of phosphodiesterases 3B, 4A4, 4D1, 4D2, and 4D3 in Jurkat T-cells and in human peripheral blood T-lymphocytes by 8-bromo-cAMP and Gs-coupled receptor agonists. Potential role in beta2-adrenoreceptor desensitization.","volume":"273","author":"Seybold","year":"1998","journal-title":"J Biol Chem."},{"key":"2020021300143092500_B37","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0006-2952(91)90047-9","article-title":"Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes.","volume":"42","author":"Robicsek","year":"1991","journal-title":"Biochem Pharmacol."},{"key":"2020021300143092500_B38","first-page":"81","article-title":"Structure and function of nuclear hormone receptors [review].","volume":"1","author":"Parker","year":"1990","journal-title":"Semin Cancer Biol."},{"key":"2020021300143092500_B39","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1046\/j.1365-2141.1997.4803282.x","article-title":"Cyclic AMP phosphodiesterases in human lymphocytes.","volume":"99","author":"Sheth","year":"1997","journal-title":"Br J Haematol."},{"key":"2020021300143092500_B40","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0006-2952(99)00188-4","article-title":"Cyclic nucleotide phosphodiesterases (PDE) 3 and 4 in normal, malignant, and HTLV-I transformed human lymphocytes.","volume":"58","author":"Ekholm","year":"1999","journal-title":"Biochem Pharmacol."},{"key":"2020021300143092500_B41","doi-asserted-by":"crossref","first-page":"11236","DOI":"10.1073\/pnas.93.20.11236","article-title":"Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells.","volume":"93","author":"Jiang","year":"1996","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021300143092500_B42","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood.V92.7.2484","article-title":"Type 4 cyclic adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocytic leukemia.","volume":"92","author":"Kim","year":"1998","journal-title":"Blood."},{"key":"2020021300143092500_B43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/10428199609051756","article-title":"In vitro and in vivo anti-leukemic efficacy of cyclic AMP modulating agents against human leukemic B-cell precursors.","volume":"22","author":"Myers","year":"1996","journal-title":"Leuk Lymphoma."},{"key":"2020021300143092500_B44","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1210\/endo.133.3.8396009","article-title":"Interactions between human immunodeficiency virus infection and hormonal pathways: enhancement of calcium-induced but reduction of glucocorticoid-induced cell death.","volume":"133","author":"Smith","year":"1993","journal-title":"Endocrinology."},{"key":"2020021300143092500_B45","first-page":"3785","article-title":"Characterization of a glucocorticoid-sensitive human lymphoid cell line.","volume":"37","author":"Norman","year":"1977","journal-title":"Cancer Res."},{"key":"2020021300143092500_B46","first-page":"631","article-title":"Identification of the activation-labile gene: a single point mutation in the human glucocorticoid receptor presents as two distinct receptor phenotypes.","volume":"7","author":"Ashraf","year":"1993","journal-title":"Mol Endocrinol."},{"key":"2020021300143092500_B47","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1365-2141.1995.tb05225.x","article-title":"Theophylline, a new inducer of apoptosis in B-CLL: role of cyclic nucleotides.","volume":"90","author":"Mentz","year":"1995","journal-title":"Br J Haematol."},{"key":"2020021300143092500_B48","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1016\/S0091-6749(96)70068-4","article-title":"Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5.","volume":"98","author":"Adachi","year":"1996","journal-title":"J Allergy Clin Immunol."},{"key":"2020021300143092500_B49","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1172\/JCI119692","article-title":"Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition.","volume":"100","author":"Yasui","year":"1997","journal-title":"J Clin Invest."},{"key":"2020021300143092500_B50","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/sj.leu.2401237","article-title":"Theophylline-induced B-CLL apoptosis is partly dependent on cyclic AMP production but independent of CD38 expression and endogenous IL-10 production.","volume":"13","author":"Mentz","year":"1999","journal-title":"Leukemia."},{"key":"2020021300143092500_B51","doi-asserted-by":"crossref","first-page":"11236","DOI":"10.1073\/pnas.93.20.11236","article-title":"Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells.","volume":"93","author":"Jiang","year":"1996","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021300143092500_B52","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1128\/MCB.12.8.3600","article-title":"Evidence that glucocorticoid- and cyclic AMP-induced apoptotic pathways in lymphocytes share distal events.","volume":"12","author":"Dowd","year":"1992","journal-title":"Mol Cell Biol."},{"key":"2020021300143092500_B53","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1096\/fasebj.7.6.8386120","article-title":"Cyclic AMP potentiates glucocorticoid-induced endogenous endonuclease activation in thymocytes.","volume":"7","author":"McConkey","year":"1993","journal-title":"FASEB J."},{"key":"2020021300143092500_B54","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1530\/eje.0.1310557","article-title":"G-proteins: implications for pathophysiology and disease.","volume":"131","author":"Gordeladze","year":"1994","journal-title":"Eur J Endocrinol."},{"key":"2020021300143092500_B55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.171.3967.189","article-title":"Glucocorticoid receptors in lymphoma cells in culture: relationship to glucocorticoid killing activity.","volume":"171","author":"Baxter","year":"1971","journal-title":"Science."},{"key":"2020021300143092500_B56","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1128\/MCB.20.13.4849-4858.2000","article-title":"p53 recruitment of CREB binding protein mediated through phosphorylated CREB: a novel pathway of tumor suppressor regulation.","volume":"20","author":"Giebler","year":"2000","journal-title":"Mol Cell Biol."},{"key":"2020021300143092500_B57","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/362849a0","article-title":"Thymocyte apoptosis induced by p53-dependent and independent pathways [see comments].","volume":"362","author":"Clarke","year":"1993","journal-title":"Nature."},{"key":"2020021300143092500_B58","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0006-291X(90)92033-V","article-title":"The dose dependent effect of cyclic AMP on ribonucleotide reductase in mitogen stimulated mononuclear cells.","volume":"167","author":"Albert","year":"1990","journal-title":"Biochem Biophys Res Commun."},{"key":"2020021300143092500_B59","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1247\/csf.23.357","article-title":"Cyclic AMP delays G2 progression and prevents efficient accumulation of cyclin B1 proteins in mouse macrophage cells.","volume":"23","author":"Kurokawa","year":"1998","journal-title":"Cell Struct Funct."},{"key":"2020021300143092500_B60","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1006\/bbrc.1998.8390","article-title":"Prevention of tumor necrosis factor (TNF)-mediated induction of p21WAF1\/CIP1 sensitizes MCF-7 carcinoma cells to TNF-induced apoptosis.","volume":"245","author":"Jiang","year":"1998","journal-title":"Biochem Biophys Res Commun."},{"key":"2020021300143092500_B61","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/10428190009057627","article-title":"The cAMP signaling pathway as a therapeutic target in lymphoid malignancies.","volume":"37","author":"Lerner","year":"2000","journal-title":"Leuk Lymphoma."},{"key":"2020021300143092500_B62","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0006-2952(98)00331-1","article-title":"Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation.","volume":"57","author":"Essayan","year":"1999","journal-title":"Biochem Pharmacol."},{"key":"2020021300143092500_B63","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2165\/00003495-200059020-00004","article-title":"Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here?","volume":"59","author":"Giembycz","year":"2000","journal-title":"Drugs."},{"key":"2020021300143092500_B64","first-page":"420","article-title":"SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions.","volume":"284","author":"Barnette","year":"1998","journal-title":"J Pharmacol Exp Ther."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/9\/3390\/1683365\/h80902003390.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/9\/3390\/1683365\/h80902003390.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T08:22:31Z","timestamp":1682324551000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/99\/9\/3390\/54159\/Inhibition-of-PDE4-phosphodiesterase-activity"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5,1]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2002,5,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v99.9.3390","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,5,1]]}}}